FIELD: medicine; oncology.
SUBSTANCE: method consists in a combined treatment using bisphosphonates for 5-10 days and mustophorane, mustophorane being injected intravenously driply once a week for 2-3 weeks in the quantity of 208 mg per one injection, 3-5 days after injection of bisphosphonates. Such courses of treatment by a combination of bisphosphonates and mustophorane are repeated in 6-8 weeks under control of indicants of peripheric blood.
EFFECT: increased efficiency of palliative treatment and a possibility to relieve a painful syndrome and improve quality of a life of patients with plural osteal metastasises of mammary gland cancer.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENT WITH OSTEOLYTIC METASTASIS | 1999 |
|
RU2153358C1 |
| METHOD OF TREATING SPINE TUMOURS | 2014 |
|
RU2551622C1 |
| METHOD FOR PREVENTING DEVELOPMENT OF LYMPHEDEMA OF UPPER EXTREMITY IN SURGICAL TREATMENT OF PATIENTS WITH BREAST CANCER | 2023 |
|
RU2815757C1 |
| METHOD OF TREATING PROSTATE CANCER PERMEATING THROUGH BONE | 2014 |
|
RU2565106C1 |
| METHOD FOR TREATING LOCALLY GENERALIZED CANCER OF THE MAMMARY GLAND WITH TUMOR-INDUCED SKIN ULCERS | 2001 |
|
RU2176922C1 |
| METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN PROSTATE CANCER | 2010 |
|
RU2460544C2 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
| METHOD FOR TREATING COMPLICATED BIOPHOSPHONATE OSTEOMYELITIS OF JAW BONES | 2019 |
|
RU2700497C1 |
| METHOD FOR TREATING MALIGNANT BONE TUMORS AND OSTEOLYTIC METASTASES IN BONE | 1997 |
|
RU2144398C1 |
| PHARMACEUTICAL BIPHOSPHONATE APPLICATION | 2002 |
|
RU2297229C2 |
